Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
ORGS
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Q2.22
N/A
-2.20
vs 1.1
Q3.22
N/A
-0.50
vs 4.2
Q4.22
N/A
-1.60
vs -2.00
Q1.23
N/A
-1.70
vs -1.60
Q2.23
N/A
-1.50
vs -2.20
Q3.23
N/A
-4.30
vs -0.50
Q1.24
N/A
-2.90
vs -1.70
Q2.24
N/A
-2.30
vs -1.50
Q3.24
N/A
-1.93
vs -4.30
Q4.24
N/A
2.5
vs NA
Sales Growth
YoY
Current
Estimates
Q2.22
-32%
7.2M vs 10.5M
Q3.22
-8%
8M vs 8.7M
Q4.22
+98%
13.6M vs 6.9M
Q1.23
-98%
142K vs 7.2M
Q2.23
-98%
113K vs 7.2M
Q3.23
-99%
110K vs 8M
Q1.24
-1%
141K vs 142K
Q2.24
+118%
246K vs 113K
Q3.24
+215%
347K vs 110K
Q4.24
NA
24.2M vs NA
Return on Equity
QoQ
Q4.22
-5%
-0.05
vs -0.05
Q1.23
-70%
-0.70
vs -0.05
Q2.23
-107%
-1.07
vs -0.70
Q3.23
-30%
-0.30
vs -1.07
Q4.23
NA
NA
vs -0.30
Q1.24
+35%
0.35
vs NA
Q2.24
+57%
0.57
vs 0.35
Q3.24
-38%
-0.38
vs 0.57
Institutionnal Ownership
QoQ
Q3.22
17
17
vs 18
-6%
Q4.22
21
21
vs 17
24%
Q1.23
20
20
vs 21
-5%
Q2.23
21
21
vs 20
5%
Q3.23
20
20
vs 21
-5%
Q4.23
20
20
vs 20
NA
Q1.24
16
16
vs 20
-20%
Q2.24
18
18
vs 16
13%
globenewswire.com
7 hours ago
accessnewswire.com
8 hours ago
globenewswire.com
17 hours ago
Forecast
20159%2024-Revenue
3311%2024-EPS
-494%2024-EBITDA
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Buy
Price Target
NaN(-100.00%)
Number of analyst
Last analyst upgrade/downgrade
No Data Available
Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network. It focuses on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient at their point of care for treatment of the patient. The company was formerly known as Business Outsourcing Service, Inc. and changed its name to Orgenesis Inc. in August 2011. Orgenesis Inc. was incorporated in 2008 and is based in Germantown, Maryland.
OTC
Unprofitable
EPS improving
Unprofitable
EPS improving
-0.02Â ( -1.52%)
Pre-market 1.29$-0.01 (-1.15%)
Relative Strenght
2
Volume Buzz
184%
Earning Acce
Yes
Dist 52w H.
88%Fundamentals
P/E Ratio
P/S Ratio
P/B Ratio
Debt/Equity
Net Margin
EPS
How ORGS compares to sector?
Relative Strength
ORGS
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|